Skip to main content

(+)-Pentazocine, [Ring-1,3-3H]-,250µCi (9.25MBq)

(+)-Pentazocine radioligand tritiated at the 1,3 position on the ring. Pentazocine is a synthetic opioid shown to bind sigma 1 receptor.

For research use only. Not for use in diagnostic procedures

Product Variants
Part number: NET1056250UC
Unit Size: 250 µCi
List price: USD 3,635.00
Your price:
USD 3,635.00
USD 3,635.00 /each
Part number: NET1056001MC
Unit Size: 1 mCi
List price: USD 9,342.00
Your price:
USD 0.00
USD 9,342.00 /each


250 µCi quantity of (+)-Pentazocine, [Ring-1,3-3H]-, is available for your research. Pentazocine functions as a sigma σ1 receptor agonist, where it has been shown to inhibit the outward current of potassium ions (K+). It is a known analgesic used to treat pain.

We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays.

Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.

References for NET1056:

  1. Dhwanil A. Dalwadi, Seongcheol Kim, John A. Schetz, Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia, In Neurochemistry International, Volume 105, 2017, Pages 21-31.
  2. José Luis Díaz, Ute Christmann, Ariadna Fernández, Antoni Torrens, Adriana Port, Rosalia Pascual, Inés Álvarez, Javier Burgueño, Xavier Monroy, Ana Montero, Ariadna Balada, José Miguel Vela, and Carmen Almansa. Synthesis and Structure–Activity Relationship Study of a New Series of Selective σ1 Receptor Ligands for the Treatment of Pain: 4-Aminotriazoles, In Journal of Medicinal Chemistry, Volume 58, Issue 5, 2015, Pages 2441-2451.


Molecular Weight
Drug Discovery & Development
NEN Radiochemicals
Detection Method
Label Position
Specifically Labeled
One Unit Contains
250.0 µCi
Receptor Type
Special Ordering Information
This is a radioactive product - shipping address must have a license to receive radioactive materials.
Therapeutic Area
Unit Size
250 µCi


1-1 of 1 Resources
Calendar Icon
2024 Fresh Lot Calendar
SDS, COAs, Manuals and more Illuminator

SDS, COAs, Manuals and more

Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.

Scroll Icon